Articles On Avita Medical (ASX:AVH)

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Metals ((AX1)) - Accent Group ((AMA)) - AMA Group ((APA)) - APA Group ((LTM)) - Arcadium Lithium ((A1N)) - ARN Media ((ABB)) - Aussie Broadband ((ASB)) - Austa...

Today, Monday the 26th of February 2024, we are happy to buy Wagners (ASX:WGN), Bapcor Limited (ASX:BAP), Super Retail Group (ASX:SUL), Cedar Woods Properties (ASX:CWP), Accent Group (ASX:AX1), Avita Medical (ASX:AVH), Jumbo Interactive (AS...

ASX health sector flat for week as broader market falls during volatile reporting season Avita Medical reports strong full year FY23 results, forecast to reach cashflow breakeven in FY25 Clinuvel Pharmaceutical H1 FY24 results below consen...

Apiam surged as high as +27pc this morning Cleanspace had a strong first half AVITA Medical’s Q4 revenue also climbed higher   Apiam Health jumps much higher after strong H1 Rural veterinary business, Apiam Animal Health (ASX:AHX), jumped...

ASX health sector falls broader market with some key names ailing in reporting season CSL Phase III trial fails to meet primary efficacy endpoint but delivers solid H1 FY24 results Neuren Pharmaceuticals falls 13% on Friday after short sel...

The Imugene Limited (ASX: IMU) share price is charging higher on Tuesday morning. At the time of writing, the immuno-oncology company's shares are up 32% to 12 cents. Why is the Imugene share price charging higher? Investors have been buyi...

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

ASX health stocks flat in past five days in line with broader markets  Avita lowers full year 2023 guidance after slower progress in its customer’s VAC processes EBOS decides against acquisition of animal care business, reportedly Greencro...

Morgans releases its ASX wound care report seeing value in Aroa Biosurgery, Avita Medical and PolyNovo Global wound care market is estimated to grow at a CAGR of 5.9% to reach US$28.6 billion by 2028 ASX wound care companies head towards p...

The Australian share market closed up more than a quarter of a per cent boosted mainly by mining stocks which surged nearly 1.4 per cent.  In the green Fortescue Mining Group (ASX:FMG) closed up after giving the go-ahead to three gree...

PainChek’s European patent HeraMed signs deal with Telstra AdAlta announced interim Phase 1 results Avita lowers 2023 guidance PainChek’s European patent application accepted PainChek (ASX: PCK) announced that the European Patent Office...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

The Avita Medical Inc (ASX: AVH) share price is having a tough morning. At the time of writing, the regenerative medicine company's shares are down 14% to $3.29. Why is the Avita Medical share price sinking? Investors have been heading to...

There are articles everywhere, including on this website, that tell you to buy this and buy that. But it's easier said than done when the world seems so troubled. People are struggling with a massive rise in the cost-of-living due to rampa...

ASX lithium shares have been flogged to death as an investment theme the last few years, so are there any real bargains left any more? It may surprise you that there definitely are. The global price for the battery ingredient has significa...

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

The Azure Minerals Ltd (ASX: AZS) share price is slightly higher on Friday amid a major shareholder's assertion that the junior explorer's takeover by a Chilean lithium giant appears unlikely to proceed. Azure shares are currently trading...

Mineral Resources Ltd (ASX: MIN) shares closed the session at $62.60 per share, down 0.32% amid the company hosting its annual general meeting (AGM) today. The S&P/ASX 200 Index (ASX: XJO) closed lower as well, down 0.67%. MinRes see...

ASX lithium share Mineral Resources Ltd (ASX: MIN) is trading at $60.30 per share, up 3.93% on Tuesday afternoon. Meantime, the S&P/ASX 200 Index (ASX: XJO) is up 0.89% at the time of writing. Much weaker lithium commodity prices in 2...

The Avita Medical Inc (ASX: AVH) share price is having a banner day. Shares in the ASX healthcare stock closed yesterday trading for $3.56. In morning trade on Tuesday, shares were swapping hands for $4.16, up a whopping 16.9%. After what...

The Sezzle Inc (ASX: SZL) share price is back from a trading halt and having a very tough time. In morning trade, the ASX share is crashing 27% to $11.75. Why is this ASX share crashing? Investors have been heading to the exits in their dr...

By Greg Peel Misled? The ASX200 wasted no time in falling back through 7000 on Friday triggering a -50 point fall to late morning, before calm was restored and the market went quiet through the afternoon. Wall Street’s fall provided the imp...

The ASX200 has finished the week, trading down just over half a per cent. All sectors lost ground with the utilities sector the weakest today, down about 1.7 per cent. In the green Explorer Saturn Metals (ASX:STN) is up more than 7...

The ASX has ended the week lower, down 0.55pc on Friday Healthcare Sector remains defiant  Small caps led by medtech names and Lake Johnston lithium hunters   The fickle Aussie sharemarket has given back on Friday all that it has made thi...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today. The telecommu...

All ASX sectors are trading in the red so far today – seeing the ASX200 down about half a per cent. Utilities are down the most, by about 1.5 per cent. Origin Energy (ASX:ORG) has lost 2.3 per cent so far – its future and potential takeo...

All ASX sectors are trading in the red so far today – seeing the ASX200 down about half a per cent. Utilities are down the most, by about 1.5 per cent. Origin Energy (ASX:ORG) has lost 2.3 per cent so far – its future and potential takeo...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a disappointing decline. At the time of writing, the benchmark index is down 0.55% to 6,976.4 points. Four ASX shares that are not letting that hol...

AVITA jumps after providing bullish guidance Anatara up after holding AGM this morning Imugene doses first patient in its Phase 1b clinical trial using azer-cel   AVITA up on bullish sales forecast Regenerative medicine biotech, AVITA Med...

The Magnis Energy Technologies Ltd (ASX: MNS) share price is ending the week deep in the red. At one stage today, the lithium-ion battery technology and materials company's shares were down as much as 57% to 3.5 cents. They have recovered...

The Avita Medical Inc (ASX: AVH) share price is catching the eye on Friday. In morning trade, the regenerative medicine company's shares are up 24% to $3.96. Why is the Avita Medical share price rocketing? Investors have been picking up Av...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

ASX health stocks rise in past five days in line with broader markets Mach7 Technologies reports record quarterly sales orders for Q1 FY24 Aroa maintains FY24 revenue growth forecast at 30% after strong Q2 Healthcare and life sciences exp...

The S&P ASX 200 fell -3.8% in October with mid-caps falling -6.94% and small-caps down -5.45% for the month S&P ASX 200 Energy was the only sector that closed October in the black with all Australian equity factors in red Dimerix...

Aroa Biosurgery forecasts business growth of up to 30% annually with product revenue guidance of NZ$73-$76 million in FY24 New study highlights positive outcomes using Myriad Matrix and Myriad Morcells in complex traumatic wounds Aroa focu...

ASX health sector falls in line with broader markets on macroeconomic factors and global geopolitical tensions Health imaging stock Volpara announces fourth consecutive quarter of operating cashflow Several ASX healthcare names with positi...

ASX-listed Impedimed Limited Pharmaceuticals (ASX:IDP), Avita Medical (ASX:AVH), and Neuren Pharmaceutical (ASX:NEU) lead in share price increase for 2023 while Lumos Diagnostics (ASX: LDX) tops third-quarter rankings.

ASX to open much lower after heavy selloff on Wall Street Tesla, United Airlines and Morgan Stanley tumbled Netflix jumped +12pc after posting best subscriber growth in years   Aussie shares are poised to open lower after a heavy selloff...

Stockhead’s Top 10 at shortly-before-11-ish, produced with mildly heavy heart, as I’m back from and all-too-brief break but would much rather be sitting on the riverbank fishing quietly and ignoring the rest of the world again. Top 10 highl...

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

Weekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquari...

ASX health sector falls in line with broader markets as macroeconomic factors continue to create volatility Dimerix soars on $230m licensing deal with ADVANZ PHARMA for DMX-200 into rare kidney disease US FDA approves Cyclofarm’s lung imag...

If you're wanting exposure to the energy sector this month, then Santos Ltd (ASX: STO) shares could be the way to do it. That's the view of analysts at Citi, which continue to rate the energy producer as a top option in the sector with ple...

It has been a tough day for Woodside Energy Group Ltd (ASX: WDS) and its fellow ASX energy shares. Investors have been selling off their shares today after oil prices sank during overnight trade. Here's the state of play at the time of wri...

ASX200 drops sharply on Wall Street worry Healthcare only sector to rise Small caps led by Noxopharm, Nimy Resources, Alderan and ECS Botanics   The ASX200 has inched below where it was at the start of 2023, while the Australian dollar...

The S&P/ASX 200 Index (ASX: XJO) is out of form and sinking deep into the red. In afternoon trade, the benchmark index is down 1.3% to 6,942.4 points. Four ASX shares that are falling more than most today are listed below. Here's why...

Regenerative skin restoration company AVITA Medical (ASX:AVH) has announced that its RECELL System won Best Product for the second year in a row at the Annual Meeting of the American Association for the Surgery of Trauma.

Do you want to turn $50,000 into $1 million? It sounds difficult, but long-term investing in ASX shares can help you achieve such dreams. Let's take a look at how you could go from a thousand-naire to a millionaire: Compounding magic The s...

ASX health sector fall in line with broader markets as macroeconomic factors create uncertainty Clinuvel down as its European label expansion of SCENESSE knocked back pending further data 2023 biotech market darling elevated to the S&P...